Morgan Stanley upgraded Intuitive Surgical and Stryker, forecasting strong demand and a $1 billion-$2 billion backlog. Analyst downgraded Nevro and Glaukos due to weak demand and valuation concerns.
We came across a bullish thesis on Intuitive Surgical, Inc. (ISRG) on Substack by Kontra Investment Xchange. In this article, ...
Shares of Intuitive Surgical Inc. ISRG advanced 1.52% to $549.95 Wednesday, on what proved to be an all-around favorable ...
I don't think a monopoly market is healthy,” said CMR co-founder Mark Slack, discussing robotic surgery pioneer Intuitive ...
Investors might want to bet on Intuitive Surgical, Inc. (ISRG), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $549.80, marking a +1.49% move from the previous day.
Health First’s Palm Bay Hospital associates, visitors and patients had an opportunity on Wednesday to “test drive” the ...
Morgan Stanley upgraded Intuitive Surgical (ISRG) to Overweight from Equal Weight with a price target of $650, up from $522, as the analyst ...
Intuitive Surgical has become a leader for numerous procedures, and we expect it to continue its growth. The company is seeing double-digit growth both in systems and consumables driving revenue.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...